This session explores the dual impact of ventilator disconnections and fluid administration on the development and progression of ventilator-induced lung injury (VILI). Attendees will learn how these factors contribute to atelectrauma and pulmonary edema and gain insights into strategies to mitigate their effects.

This talk sheds light on the often overlooked phenomenon of airway closure and its potential role in ventilator-induced lung injury (VILI). Attendees will gain insight into the potential mechanisms behind airway closure and how to determine airway opening pressure.

This presentation focuses on the increased understanding of pendelluft as a physiological phenomenon and potential contributor to ventilator-induced lung injury (VILI). Attendees will explore the physiological underpinnings, implications of these phenomena, and strategies to mitigate their effects in mechanically ventilated patients.

This session highlights the importance of understanding the heterogeneity within Acute Respiratory Distress Syndrome (ARDS) for personalized management strategies. Participants will explore how identifying ARDS phenotypes can improve our pathophysiological understanding, trial design and optimize outcomes via targeted interventions.

Being prepared for emergencies is essential for respiratory patients. This is intensified when transporting patients, as resources are often further limited. This panel discussion will highlight the importance of checklists for safety when transporting patients.

Evidence to support the use of modulator therapies in cystic fibrosis is rapidly growing. The evolving role of CF modulators in disease progression, airway clearance, and long-term outcomes will be discussed through an examination of the most impactful papers published in the last calendar year.

Neonatal mechanical ventilation requires careful application and sophisticated monitoring to assure safety and efficacy. This presentation will discuss the most important papers regarding advances in neonatal mechanical ventilation in the last year.

High flow nasal cannula has proven to be an effective method for supporting oxygenation and mild hypercapnia in patients with COPD. Patient comfort is a major advantage of HFNC. This presentation will provide a description of important papers published last year related to the application of HFNC in patients with COPD.

This presentation will review the literature on pulmonary rehabilitation published in the last year. This will include telerehabilitation and cover the newly published guidelines on pulmonary rehabilitation.

This presentation will discuss the research published in the last year related to the measurement and impact of mechanical power during mechanical ventilation.

Implementation science is a field that promotes the incorporation of evidence-based treatments and interventions into real-world practice to improve patient outcomes. It focuses on identifying and addressing barriers to adoption, integration, and maintenance of effective practices, aiming to bridge the gap between what has been demonstrated to improve outcomes versus what is commonly practiced at the bedside. A prime example is the use of lung protective tidal volumes in ARDS. This presentation will highlight the role of implementation science in the safe and effective delivery of mechanical ventilation.

Sponsored by Nihon Kohden and Dr. Honglin Du

An understanding of physiology is fundamental to respiratory care practice. Unfortunately, physiological principles, after memorization in school, are often forgotten once entering practice. This lecture covers several physiological principles relevant to every respiratory care practice, linking physiology to practice.

Clinicians assess patients requiring mechanical ventilation at regular intervals as part of a patient-ventilator assessment (PVA). In addition, spontaneous breathing trials (SBTs) facilitate liberation from mechanical ventilation and are an important clinical tool. The first half of this presentation will review the evidence and final recommendations for PVA implementation. This includes ventilator synchrony, dyspnea, distress, alarms, and graphics. The second half will review evidence for SBTs in facilitating liberation from mechanical ventilation. The evidence discussed includes criteria needed to perform SBTs, duration of SBTs, the use of rest settings, delaying extubation if decreased mental status is present, and the use of NIV and HFNC to screen for extubation failure.

The interplay of respiratory and cardiovascular physiology in critically ill patients on mechanical ventilation is complex but crucial as it may guide the clinician’s therapeutic decisions and, possibly, affect patient outcome. This presentation will provide an overview of the concepts of heart-lung interactions during mechanical ventilation and the effects of positive pressure ventilation on preload and afterload of the right and left ventricular as well as pulmonary vascular resistance.

Health disparities exist especially among individuals whose income is at or below the federal poverty level. Social drivers of health include social, economic, and environmental factors, and play a vital role in these disparities. This lecture will focus on how social drivers of health significantly affect adults with pulmonary disorders and negatively impact pulmonary health outcomes. The impact respiratory therapists can make by integrating a social driver assessment into their practice to improve the health of their patients will be discussed.

Data for appropriately and effectively utilizing non-invasive respiratory support in patients with both increasing and decreasing acuity is rapidly emerging. An overview of the most recent guidance for the use of high flow nasal oxygen and non-invasive ventilation in acute respiratory failure will be reviewed.

Management of COPD patients and coordination of their care in both the inpatient and outpatient settings can be complicated by common comorbid conditions. When combined with factors like rurality, outcomes for patients with COPD can be greatly affected. This presentation will also discuss the impact that rurality and comorbid conditions related to rurality have on COPD outcomes.